Skip to content

This is a study to test the effectiveness of electrical nerve stimulation treatment applying on superficial skin in patients having pain originating from nerves and muscles of facial region.

A Comparitive study among treatment modalities of orofacial pain of neural and muscular origin with transcutaneous electric nerve stimulation therapy

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/02/012068
Enrollment
28
Registered
2018-02-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Trigeminal neuralgia and Myofacial pain dysfunction syndrome

Interventions

Intervention1: Transcutaneous electric nerve stimulation: Transcutaneous electric nerve stimulation with 0-11 pulse rate, pulse width of 1-11µsec for 30 min,alternate days for 2 weeks for trigemina

Sponsors

Dr G Swathi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with orofacial pain due to neural & muscular origin. 2. Patients who are willing to give written consent to be treated with TENS will be included in the study.

Exclusion criteria

Exclusion criteria: 1. Patients who are having pacemakers or other implanted electrical devices. 2. Pregnancy and lactating mothers. 3. Patients with pain attributable to fracture to joint, dental surgery, neoplasm.

Design outcomes

Secondary

MeasureTime frame
Frequency of pain attacks per dayTimepoint: Frequency of pain attacks per day-15 Days

Primary

MeasureTime frame
Reduction in pain intensity and measurement of it using Visual analogue scoreTimepoint: Reduction in pain intensity and measurement of it using Visual analogue score-15 days

Countries

India

Contacts

Public ContactDr T Ramesh

Vishnu dental college

drramesht@gmail.com9440847997

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026